Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Pharmacology

• Publication date

  2000-11-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(00)00752-4PMID 11068023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.

  2000cited by this paper
• In vivo characterization of p‐[18F]MPPF, a fluoro analog of WAY‐100635 for visualization of 5‐HT1a receptors

  2000cited by this paper
• Quantitative imaging of 5-HT(1A) receptor binding in healthy volunteers with [(18)f]p-MPPF.

  2000cited by this paper
• Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.

  1999cited by this paper
• 5-HT1A Receptors visualization with p-[18F]MPPF in healthy volunteers.

  1999cited by this paper
• Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.

  1998cited by this paper
• Validation of S-1'-[18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors.

  1998cited by this paper
• Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

  1998cited by this paper
• Complete in vivo reversal of P‐glycoprotein pump function in the blood‐brain barrier visualized with positron emission tomography

  1998cited by this paper
• High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635.

  1998cited by this paper
• Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats

  1998cited by this paper
• Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism.

  1997cited by this paper
• p‐[18F]‐MPPF: A potential radioligand for PET studies of 5‐HT1A receptors in humans

  1997cited by this paper
• The functional role of P-glycoprotein in the blood-brain barrier.

  1997cited by this paper
• Transporting therapeutics across the blood-brain barrier.

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• What have we learnt thus far from mice with disrupted P-glycoprotein genes?

  1996cited by this paper
• Short Communication New 5‐HT1A receptor antagonist: [3H]p‐MPPF

  1996cited by this paper
• Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.

  1996cited by this paper
• Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.

  1995cited by this paper
• Sep Pak as alternative to rotary evaporators for radiopharmaceutical formulations.

  1995cited by this paper
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.

  1994cited by this paper
• Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.

  1994cited by this paper
• Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.

  1994cited by this paper
• Structural requirements of simple organic cations for recognition by multidrug-resistant cells.

  1992cited by this paper
• Chapter 24: The interaction of some centrally active drugs with the blood-brain barrier and circumventricular organs

  1992cited by this paper
• NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.

  1990cited by this paper
• Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance.

  1990cited by this paper
• NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

  1988cited by this paper
• Synthesis and Evaluation

  1986cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.

  1981cited by this paper

• Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges

  2023cites this paper
• Applications, Advances, and Limitations of Molecular Imaging of Brain Receptors

  2021cites this paper
• PET Imaging of ABC Transporters at the Blood-Brain Barrier

  2020cites this paper
• [PET imaging to study the functional impact of P-glycoprotein in neuropharmacokinetics].

  2020cites this paper
• Imaging Mechanisms of Drug Resistance in Experimental Models of Epilepsy

  2019cites this paper
• PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling

  2019cites this paper
• Preclinical Testing of Novel Radiotracers for Positron Emission Tomography (PET)

  2017cites this paper
• New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.

  2017cites this paper
• F-FCWAY , a serotonin 1 A receptor radioligand , is a substrate for ef fl ux transport at the human blood-brain barrier

  2016cites this paper
• Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

  2016cites this paper
• 5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better?

  2016cites this paper
• 18F-Mefway PET Imaging of Serotonin 1A Receptors in Humans: A Comparison with 18F-FCWAY

  2015cites this paper
• First-in-Human Evaluation of 18F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors

  2014cites this paper
• Small-animal single-photon emission computed tomographic imaging of the brain serotoninergic systems in wild-type and mdr1a knockout rats.

  2014cites this paper
• First-inHuman Evaluation of 18 F-Mefway , a PET Radioligand Specific to Serotonin-1 A Receptors

  2014cites this paper
• Small-Animal Single-Photon Emission Computed Tomographic Imaging of the Brain Serotoninergic Systems in Wild-Type and Mdrla Knockout Rats

  2014cites this paper
• N-(4-[(18)F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT(1A) receptors.

  2014cites this paper
• Determination of optimal acquisition time of [(18)F]FCWAY PET for imaging serotonin 1A receptors in the healthy male subjects.

  2014cites this paper
• 5‐HT radioligands for human brain imaging with PET and SPECT

  2013cites this paper
• Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

  2013cites this paper
• Optimization of the radiosynthesis of [(18) F]MEFWAY for imaging brain serotonin 1A receptors by using the GE TracerLab FXFN-Pro module.

  2013cites this paper
• Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.

  2013cites this paper
• Discrepancies in the P-glycoprotein-Mediated Transport of 18F-MPPF: A Pharmacokinetic Study in Mice and Non-human Primates

  2012cites this paper
• Serotonin-1A receptors in major depression quantified using PET: Controversies, confounds, and recommendations

  2012cites this paper
• Synthesis, biodistribution and PET studies in rats of (18)F-Labeled bridgehead fluoromethyl analogues of WAY-100635.

  2012cites this paper
• Apports de la TEP dans l’imagerie moléculaire des récepteurs sérotoninergiques 5-HT1A et 5-HT7

  2011cites this paper
• Avoiding Barriers to PET Radioligand Development: Cellular Assays of Brain Efflux Transporters

  2011cites this paper
• [76Br]BMK‐152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin‐releasing factor type 1 receptor

  2011cites this paper
• PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

  2011influential citation
• Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain.

  2011cites this paper
• In vivo kinetics of [F‐18]MEFWAY: A comparison with [C‐11]WAY100635 and [F‐18]MPPF in the nonhuman primate

  2011cites this paper
• Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT(1A) receptors.

  2010cites this paper
• Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.

  2010cites this paper
• Imaging of P‐glycoprotein–mediated pharmacoresistance in the hippocampus: Proof‐of‐concept in a chronic rat model of temporal lobe epilepsy

  2010influential citation
• In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography.

  2010cites this paper
• Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs.

  2010cites this paper
• Evaluation of [11C]S14506 and [18F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT1A receptors

  2010cites this paper
• Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: Effects of the novel P-glycoprotein inhibitor tariquidar

  2010influential citation
• Design and evaluation of novel PET and SPECT tracers for imaging the monoamine system and the P-gp transporter

  2009cites this paper
• In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [(11)C]gefitinib.

  2009cites this paper
• Development and characterisation of a new model of rat trophoblasts.

  2009cites this paper
• PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

  2009cites this paper
• Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

  2009cites this paper
• Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies

  2008influential citation
• Species differences in blood-brain barrier transport of three PET radioligands with emphasis on P-glycoprotein transport

  2008cites this paper
• [18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain.

  2007cites this paper
• Disulfiram Inhibits Defluorination of 18F-FCWAY, Reduces Bone Radioactivity, and Enhances Visualization of Radioligand Binding to Serotonin 5-HT1A Receptors in Human Brain

  2007cites this paper
• In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.

  2007influential citation
• Effect of a P‐glycoprotein inhibitor, cyclosporin A, on the disposition in rodent brain and blood of the 5‐HT1A receptor radioligand, [11C](R)‐(––)‐RWAY

  2007cites this paper
• Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.

  2006cites this paper
• Quantification of serotonin 5‐HT1A receptors in monkey brain with [11C](R)‐(−)‐RWAY

  2006cites this paper
• Development of 5‐HT1A receptor radioligands to determine receptor density and changes in endogenous 5‐HT

  2006cites this paper
• Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds.

  2005cites this paper
• Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.

  2005cites this paper
• Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors.

  2005cites this paper
• Two C-Methyl Derivatives of [11C]WAY-100635 – Effects of an Amido α-Methyl Group on Metabolism and Brain 5-HT1A Receptor Radioligand Behavior in Monkey*

  2005cites this paper
• N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.

  2005cites this paper
• Positron Emission Tomography Studies on Binding of Central Nervous System Drugs and P-Glycoprotein Function in the Rodent Brain

  2005cites this paper
• The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.

  2004cites this paper
• Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain

  2004cites this paper
• PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

  2004cites this paper
• Drug efflux transporters in the CNS.

  2003cites this paper
• Different brain kinetics of two sigma1 receptor ligands, [3H](+)‐pentazocine and [11C]SA4503, by P‐glycoprotein modulation

  2003cites this paper
• Radiopharmaceutical chemistry for positron emission tomography.

  2002cites this paper
• Dedicated small animal scanners: a new tool for drug development?

  2002cites this paper
• Chapter 26. PET ligands for assessing receptor occupancy in vivo

  2001cites this paper
• Expression und Funktion arzneimittelmetabolisierender Enzyme und des ABC-Transporters P-Glykoprotein in Dünndarm und Leber des Menschen.

  2000cites this paper